Urinary excretion of 3',5'-AMP in syndromes considered refractory to parathyroid hormone.
D000227:Adenine Nucleotides / Q000652:urine*; D001479:Basal Ganglia / Q000473:pathology*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000652:urine*; D002114:Calcinosis / Q000188:drug therapy / Q000652:urine*; D002869:Chromosome Aberrations; D025063:Chromosome Disorders; D003404:Creatinine / Q000652:urine; D000242:Cyclic AMP / Q000652:urine; D005260:Female; D006801:Humans; D007417:Intestinal Polyps / Q000235:genetics*; D008297:Male; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy / Q000652:urine*; D009508:Nevus, Pigmented / Q000188:drug therapy / Q000652:urine*; D010018:Osteomalacia / Q000188:drug therapy / Q000235:genetics* / Q000652:urine*; D010281:Parathyroid Hormone / Q000627:therapeutic use*; D010710:Phosphates / Q000652:urine; D011547:Pseudohypoparathyroidism / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy / Q000652:urine*; D014807:Vitamin D / Q000627:therapeutic use
D000227:Adenine Nucleotides; D010281:Parathyroid Hormone; D010710:Phosphates; D014807:Vitamin D; D003404:Creatinine; D000242:Cyclic AMP